false
zh-CN,zh-TW,en,fr,de,ja,ko,pt,es,th,vi
Catalog
2023 ACMG Annual Clinical Genetics Meeting Digital ...
Sequence and copy number variant detection in auto ...
Sequence and copy number variant detection in autosomal recessive conditions utilizing tiered-testing approach
Back to course
Pdf Summary
A tiered-testing approach that combines chromosomal microarray analysis (CMA) and whole exome sequencing (WES) is effective in diagnosing autosomal recessive neurodevelopmental disorders. In a case series presented by Bionano Laboratories, it is shown that both copy number variants and sequence variants are important for a comprehensive evaluation of these disorders. The first-line diagnostic test is CMA, which detects copy number variants. However, it has limitations in terms of detection rates. WES is used as a subsequent test and helps to detect sequence variants. The combination of both tests allows for broad genomic detection and adheres to current medical guidelines.<br /><br />The significance of this tiered approach lies in its ability to provide a more complete evaluation of multiple genetic variants, leading to better clinical management. The cases presented in the study demonstrate how this approach can optimize clinical outcomes and shorten diagnostic odysseys for individuals with neurodevelopmental disorders. The study underscores the importance of accurate detection of both copy number and sequence variants in the evaluation of autosomal recessive disorders.<br /><br />The study presents five cases of individuals with neurodevelopmental disorders who were diagnosed using the tiered-testing approach. The cases involve individuals with conditions such as limb-girdle muscular dystrophy, oculocutaneous albinism, Cohen syndrome, WWOX-related disorder, and juvenile Parkinson disease. In each case, both copy number variants and sequence variants were detected, leading to an autosomal recessive diagnosis.<br /><br />Overall, the study highlights the efficacy of the reflexive, guideline-driven testing strategy in the evaluation of autosomal recessive neurodevelopmental disorders. By combining CMA and WES, this approach allows for comprehensive genomic detection while adhering to current medical guidelines.
Asset Subtitle
Co-Author - Abby Stevens, MS; Co-Author - Anjana Varma, MS, MSGC; Presenting Author - Megan Martin, MS, CGC; Co-Author - Colleen G. Bilancia, PhD;
Meta Tag
array CGH
Chromosomal Abnormalities
Clinical Applications of Molecular Cytogenetics
Clinical Cytogenetics
Exome sequencing
Genetic Testing
Microarray
Co-Author
Abby Stevens, MS
Co-Author
Anjana Varma, MS, MSGC
Co-Author
Colleen G. Bilancia, PhD
Presenting Author
Megan Martin, MS, CGC
Keywords
tiered-testing approach
chromosomal microarray analysis
CMA
whole exome sequencing
WES
autosomal recessive neurodevelopmental disorders
copy number variants
sequence variants
genomic detection
medical guidelines
© 2024 American College of Medical Genetics and Genomics. All rights reserved.
×